Walgreens launches own brand of opioid overdose reversal drug [Yahoo! Finance]
Emergent Biosolutions, Inc. (EBS)
Last emergent biosolutions, inc. earnings: 4/30 04:08 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.emergentbiosolutions.com
Company Research
Source: Yahoo! Finance
The launch comes weeks after Walgreens' brand was approved by the U.S. Food and Drug Administration in April. WHY IT'S IMPORTANT Opioid abuse has plagued the United States for more than two decades and killed more than half a million Americans, with fentanyl and synthetic versions being a major culprit in recent years, according to government data. Naloxone rapidly reverses or blocks the effects of opioids, restoring normal respiration, especially when given within minutes of the first signs of an overdose. It is seen as a key tool to help in surviving an opioid overdose. CONTEXT The U.S. FDA approved an OTC version of Emergent Biosolutions' Narcan last year, aimed at making it easier to access without a prescription. The health regulator had approved the first generic version of the medication in 2021, sold by Israeli drugmaker Teva Pharmaceuticals. Other drugmakers also sell various versions of the product, and privately held Harm Reduction Therapeutics' naloxone-ba
Show less
Read more
Impact Snapshot
Event Time:
EBS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EBS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EBS alerts
High impacting Emergent Biosolutions, Inc. news events
Weekly update
A roundup of the hottest topics
EBS
News
- Walgreens launches its own opioid reversal therapy for OTC use [Seeking Alpha]Seeking Alpha
- Walgreens launches own brand of opioid overdose reversal drug [Reuters]Reuters
- Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024 [Yahoo! Finance]Yahoo! Finance
- Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024GlobeNewswire
- Emergent Biosolutions lays off 300 people [Yahoo! Finance]Yahoo! Finance
EBS
Earnings
- 3/6/24 - Miss
EBS
Sec Filings
- 5/29/24 - Form 8-K
- 5/28/24 - Form 4
- 5/28/24 - Form 4
- EBS's page on the SEC website